CTOs on the Move

Shared Health Services

www.sharedhealthservices.com

 
Shared Health Services is a wound care management company that contracts with hospitals to help them open and manage successful outpatient wound care and hyperbaric centers. The mission of our Wound Care Centers is to heal chronic wounds, improve patient outcomes, help prevent limb loss and provide a profitable service for our contracted hospitals.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Kind and Total Health System

Kind and Total Health System is a Alhambra, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kolmar Laboratories Inc

Kolmar Laboratories Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Kolmar Laboratories Inc is based in Port Jervis, NY. You can find more information on Kolmar Laboratories Inc at www.kolmar.com

Elbert Memorial Hospital

Elbert Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Elberton, GA. To find more information about Elbert Memorial Hospital, please visit www.emhcare.net

Compass Health

Compass Health`s mission is to champion the quest for well-being throughout our communities, and advance behavioral health in Snohomish, Skagit, Island, San Juan, and Whatcom counties. Compass Health was first established as Parkland Lutheran Children’s Home in 1901, caring for orphaned children in Western Washington.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.